Abstract
Pseudomyxoma peritonei (PMP) is a rare condition with inevitable persistence and progression. Although its etiology is controversial, commonest site of the origin is the appendix and the ovary. In this study, our purpose is to discuss PMP and to share our experience. In our clinic, two patients, a male and a female with a diagnosis of PMP were operated. Two patients died because of tumor recurrences. Even though PMP is not considered aggressive biologically and there is not a lymph node metastasis and invasion, it is eventually fatal with recurrences and progression of the disease. Due to rarity and heterogenicity of the condition, the treatment of PMP is subject of discussion.
Keywords:
Pseudomyxoma peritonei, intraperitoneal chemotherapy, peritonectomy
References
1
Fann JI, Vierra M, Fisher D, Oberhelman HA Jr, Cobb L. Pseudomyxoma peritonei. Surg Gynecol Obstet 1993; 177: 441-447.
2
Werth R. Klinische und Anastomische Untersuchungen Zur Lehre von der Bauchgeschwullsten und der Laparotomie. Arch Gynecol Obstet 1884; 84: 100-118.
3
Frankel E. Uher das sogenanute pseudomixoma peritonei. Med Wochenschr 1901; 48: 965-970.
4
Sherer DM, Abulafia O. Eliakim R. Pseudomyxoma peritonei: A review of current literature. Gynecol Obstet Invest 2001; 51: 73-80.
5
Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85: 1332-1339.
6
Young RH, Gilks CB, Scully RE. Pseudomyxoma peritonei. Am J Surg Pathol 1993; 17: 1068-1071.
7
Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei: a clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18: 591-603.
8
Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the pattens of spread. Cancer Metastasis Rev 2003; 22: 465-472.
9
Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003; 12: 585-603.
10
Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B. Elevated tumor markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 2005; 7: 382-386.
11
Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, Dalton RR, Ettinghausen SE, Jacquet P, Jelinek J, Koslowe P, Kurman RJ, Shmookler B, Stephens MA, Stuart OA, White S, Zahn CM, Zoetmulder FA. Pseudomyxoma peritonei syndrome. Adv Surg 1997; 30: 233-280.
12
Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P. Systematic review of the Sugarmaker procedure for pseudomyxoma peritonei. Br J Surg 2005; 92: 153-158.
13
Deraco M, Baratti D, Inglesse MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has comfirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004; 11: 393-398.
